Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company's segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe. The Genus ABS segment is engaged in bovine sales business, excluding Asia, and serves dairy and beef customers in North America, Latin America and Europe. The Genus Asia segment is engaged in porcine and bovine business in Asia, and serves porcine, dairy and beef customers in Asian markets. In the porcine market, it sells boars and sows. In the dairy and beef markets, its primary product is bull semen. The Company offers embryos through its subsidiary, In Vitro Brasil S.A. Its porcine business has a network of over 600 breeding herds in approximately 40 countries.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Biotechnology & Medical Research - NEC
- Sub-Industry: N/A
- Symbol: LON:GNS
- CUSIP: N/A
- Web: www.genusplc.com/
- Market Cap: £1.07 billion
- Outstanding Shares: 60,900,000
- 50 Day Moving Avg: GBX 1,819.88
- 200 Day Moving Avg: GBX 1,789.42
- 52 Week Range: GBX 1,671.72 - GBX 2,113
Sales & Book Value:
- Trailing P/E Ratio: 23.08
- P/E Growth: 0.00
- Annual Revenue: £422.1 million
- Price / Sales: 2.54
- Book Value: GBX 6.56 per share
- Price / Book: 2.68
- EBIDTA: ($29,600,000.00)
- Net Margins: 3.96%
- Return on Equity: 4.17%
- Return on Assets: 2.26%
- Average Volume: 60,798 shs.
Frequently Asked Questions for Genus plc (LON:GNS)
What is Genus plc's stock symbol?
Genus plc trades on the London Stock Exchange (LON) under the ticker symbol "GNS."
How often does Genus plc pay dividends? What is the dividend yield for Genus plc?
Genus plc declared a dividend on Thursday, February 23rd. Shareholders of record on Thursday, March 2nd will be paid a dividend of GBX 7.40 per share on Friday, March 31st. This represents a yield of 0.43%. The ex-dividend date is Thursday, March 2nd. The official announcement can be viewed at this link. View Genus plc's Dividend History.
When will Genus plc make its next earnings announcement?
Who are some of Genus plc's key competitors?
Some companies that are related to Genus plc include Blueprint Medicines Corporation (BPMC), Emergent Biosolutions (EBS), Foundation Medicine (FMI), Momenta Pharmaceuticals (MNTA), Global Blood Therapeutics (GBT), Medpace Holdings (MEDP), Genomic Health (GHDX), Esperion Therapeutics (ESPR), Immunomedics (IMMU), Cellectis S.A. (CLLS), Heron Therapeutics (HRTX), Albany Molecular Research (AMRI), Biohaven Pharmaceutical Holding Co Ltd (BHVN), TG Therapeutics (TGTX), Arena Pharmaceuticals (ARNA), Enanta Pharmaceuticals (ENTA), CRISPR THERAPTC (CRSP) and Mesoblast Limited (MESO).
Who are Genus plc's key executives?
Genus plc's management team includes the folowing people:
- Karim Bitar, Chief Executive, Executive Director
- Stephen Wilson, Group Finance Director, Executive Director
- Jonathan Lightner, Chief Scientific Officer and Head of Genus R&D
- Dan Hartley, Group General Counsel & Company Secretary
- Catherine Janet Glickman, Group Human Resources Director
- Bill Christianson, Chief Operating Officer - Genus PIC
- Saskia Korink Romani, Chief Operating Officer - Genus ABS
- Jerry Thompson, Chief Operating Officer - Genus Asia
- Robert A. Lawson, Non-Executive Independent Chairman of the Board
- Lysanne Gray, Non-Executive Director
How do I buy Genus plc stock?
Shares of Genus plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Genus plc's stock price today?
MarketBeat Community Rating for Genus plc (LON GNS)MarketBeat's community ratings are surveys of what our community members think about Genus plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Genus plc stock can currently be purchased for approximately GBX 1,759.
Consensus Ratings for Genus plc (LON:GNS) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||3 Hold Ratings, 3 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.50)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Genus plc (LON:GNS)
(Data available from 7/22/2015 forward)
|7/10/2017||Liberum Capital||Reiterated Rating||Buy|
|6/1/2017||Peel Hunt||Reiterated Rating||Buy|
|4/4/2017||Numis Securities Ltd||Reiterated Rating||Hold|
|4/3/2017||N+1 Singer||Reiterated Rating||Hold|
|3/23/2017||Berenberg Bank||Initiated Coverage||Hold|
|8/16/2016||HSBC Holdings plc||Reiterated Rating||Buy|
Earnings History for Genus plc (LON:GNS)Earnings History by Quarter for Genus plc (LON GNS)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Genus plc (LON:GNS)
Current Year EPS Consensus Estimate: $64.47 EPS
Dividend History by Quarter for Genus plc (LON GNS)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Genus plc (LON:GNS)Insider Trades by Quarter for Genus plc (LON:GNS)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/27/2016||Karim Bitar||Insider||Sell||1,648||GBX 1,945||£32,053.60|
|9/8/2016||Lawson,Robert (Bob)||Insider||Buy||1,356||GBX 1,972||£26,740.32|
|3/30/2016||Glickman ,Catherine||Insider||Buy||1,994||GBX 1,519||£30,288.86|
|3/9/2016||Broek,Lykele van der||Insider||Buy||3,750||GBX 1,458||£54,675|
|3/12/2015||Dan Hartley||Insider||Sell||6,826||GBX 1,334.50||£91,092.97|
Headline Trends for Genus plc (LON:GNS)
Latest Headlines for Genus plc (LON:GNS)
Genus plc (GNS) Chart for Saturday, July, 22, 2017